Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Regulation and Function of the L-Type Amino Acid Transporter 1 (LAT1) in Cancer
Travis B. Salisbury, Subha Arthur
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 8, pp. 2373-2373
Open Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

The Diverse Functions of Non-Essential Amino Acids in Cancer
Bo-Hyun Choi, Jonathan L. Coloff
Cancers (2019) Vol. 11, Iss. 5, pp. 675-675
Open Access | Times Cited: 174
L-Type amino acid transporter 1 as a target for drug delivery
Elena Puris, Mikko Gynther, Seppo Auriola, et al.
Pharmaceutical Research (2020) Vol. 37, Iss. 5
Open Access | Times Cited: 142
Impacts and mechanisms of metabolic reprogramming of tumor microenvironment for immunotherapy in gastric cancer
Lin Zhao, Yuanyuan Liu, Simiao Zhang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 4
Open Access | Times Cited: 74
First-in-human phase I study of JPH203, an L-type amino acid transporter 1 inhibitor, in patients with advanced solid tumors
Naohiro Okano, Daisuke Naruge, Kirio Kawai, et al.
Investigational New Drugs (2020) Vol. 38, Iss. 5, pp. 1495-1506
Closed Access | Times Cited: 109
HIF: a master regulator of nutrient availability and metabolic cross‐talk in the tumor microenvironment
Rindert Missiaen, Nicholas P. Lesner, M. Celeste Simon
The EMBO Journal (2023) Vol. 42, Iss. 6
Open Access | Times Cited: 35
Sulfur metabolism and its contribution to malignancy
Nathan P. Ward, Gina M. DeNicola
International review of cell and molecular biology (2019), pp. 39-103
Closed Access | Times Cited: 61
Review of the Correlation of LAT1 With Diseases: Mechanism and Treatment
Jingshun Zhang, Ying Xu, Dandan Li, et al.
Frontiers in Chemistry (2020) Vol. 8
Open Access | Times Cited: 61
Fatty acid metabolism is related to the immune microenvironment changes of gastric cancer and RGS2 is a new tumor biomarker
Shifeng Yang, Boshi Sun, Wenjing Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 31
Role of mammalian target of rapamycin (mTOR) signalling in oncogenesis
Mohamed El‐Tanani, Hamdi Nsairat, Alaa A. A. Aljabali, et al.
Life Sciences (2023) Vol. 323, pp. 121662-121662
Closed Access | Times Cited: 19
Branched‐Chain Amino Acids Deficiency Promotes Diabetic Neuropathic Pain Through Upregulating LAT1 and Inhibiting Kv1.2 Channel
Ze‐Yu Zhou, J. H. Wang, Zhixiao Li, et al.
Advanced Science (2024) Vol. 11, Iss. 33
Open Access | Times Cited: 8
Intricacies of the Molecular Machinery of Catecholamine Biosynthesis and Secretion by Chromaffin Cells of the Normal Adrenal Medulla and in Pheochromocytoma and Paraganglioma
Annika M.A. Berends, Graeme Eisenhofer, Lauren Fishbein, et al.
Cancers (2019) Vol. 11, Iss. 8, pp. 1121-1121
Open Access | Times Cited: 49
Characterization of the expression of LAT1 as a prognostic indicator and a therapeutic target in renal cell carcinoma
Kosuke Higuchi, Shinichi Sakamoto, Keisuke Ando, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 43
L-type amino acid transporter 1 is associated with chemoresistance in breast cancer via the promotion of amino acid metabolism
Miku Sato, Narumi Harada‐Shoji, Takafumi Toyohara, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 38
Gilteritinib Inhibits Glutamine Uptake and Utilization in FLT3-ITD–Positive AML
Megan E. Zavorka Thomas, Xiyuan Lu, Zahra Talebi, et al.
Molecular Cancer Therapeutics (2021) Vol. 20, Iss. 11, pp. 2207-2217
Open Access | Times Cited: 37
The role of the glutamine transporter ASCT2 in antineoplastic therapy
Estefânia Teixeira, Cláudia Silva, Fátima Martel
Cancer Chemotherapy and Pharmacology (2021) Vol. 87, Iss. 4, pp. 447-464
Closed Access | Times Cited: 35
Targeting the methionine addiction of cancer.
Joni C Sedillo, Vincent L. Cryns
PubMed (2022) Vol. 12, Iss. 5, pp. 2249-2276
Closed Access | Times Cited: 24
Cationic Amino Acid Transporter-1-Mediated Arginine Uptake Is Essential for Chronic Lymphocytic Leukemia Cell Proliferation and Viability
Anke Werner, Daniel Pieh, Hakim Echchannaoui, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 37
Solute carrier proteins and c-Myc: a strong connection in cancer progression
Suman Panda, Nilanjan Banerjee, Subhrangsu Chatterjee
Drug Discovery Today (2020) Vol. 25, Iss. 5, pp. 891-900
Closed Access | Times Cited: 36
Expression of 3-Methylcrotonyl-CoA Carboxylase in Brain Tumors and Capability to Catabolize Leucine by Human Neural Cancer Cells
Eduard Gondáš, Alžbeta Trančíková, Eva Baranovičová, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 585-585
Open Access | Times Cited: 20
The effects of environmental aryl hydrocarbon receptor ligands on signaling and cell metabolism in cancer
Sean A. Piwarski, Travis B. Salisbury
Biochemical Pharmacology (2023) Vol. 216, pp. 115771-115771
Closed Access | Times Cited: 13
UGCG influences glutamine metabolism of breast cancer cells
Nina Schömel, Sarah E. Hancock, Lisa Gruber, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 31
The Harmonious Interplay of Amino Acid and Monocarboxylate Transporters Induces the Robustness of Cancer Cells
Go J. Yoshida
Metabolites (2021) Vol. 11, Iss. 1, pp. 27-27
Open Access | Times Cited: 27
Lifetime Impact of Cow’s Milk on Overactivation of mTORC1: From Fetal to Childhood Overgrowth, Acne, Diabetes, Cancers, and Neurodegeneration
Bodo C. Melnik
Biomolecules (2021) Vol. 11, Iss. 3, pp. 404-404
Open Access | Times Cited: 27
SLFN5 Regulates LAT1-Mediated mTOR Activation in Castration-Resistant Prostate Cancer
Rafael S. Martinez, Mark J. Salji, Linda Rushworth, et al.
Cancer Research (2021) Vol. 81, Iss. 13, pp. 3664-3678
Open Access | Times Cited: 26
A Review on the Role of Human Solute Carriers Transporters in Cancer
Md. Shafiul Hossen, Mohammed Shafin Ul Islam, Mohammad Yasin Mohammad, et al.
Health Science Reports (2025) Vol. 8, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top